SEC Form 4 · accession 0001144204-15-062575
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karl Johe
Officer — Chief Scientific Officer · Director
Period of report
Nov 2, 2015
Accepted (ET)
Nov 3, 2015 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 2, 2015 | S | 25,000 | $1.1742 | D | 876,304 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported was effected pursuant to a 10b-5 trading plan. The sales are being made in connection with Reporting Person's divorce settlement.
- F2This transaction was executed in multiple trades at prices ranging from $1.12 to $1.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected